Biogen wins discovery for potential IP lawsuit against Sandoz

Intellectual Property 2021-12-22 8:47 pm By Bianca Hrovat | Sydney

Swiss pharmaceutical company Biogen has won discovery of documents sent from Sandoz to the Therapeutic Goods Administration, as it weighs a third patent infringement lawsuit to protect its multiple sclerosis drug against generic reproductions.